SCHEMBL8961513

SCHEMBL8961513

C=CCOc1cncc(C2CN3CCC2C3)n1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.40
CHRM2 P08172 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9064276 0.94 CHRM2 (0.35) CHRM1CHRM2
SCHEMBL9459083 0.84 CHRM1 (0.42) CHRM1CHRM2
SCHEMBL9458552 0.79 CHRM2 (0.42) CHRM1CHRM2
SCHEMBL9458763 0.76 CHRM2 (0.39) CHRM1CHRM2
SCHEMBL9584936 0.73 CHRM2 (0.41) CHRM1CHRM2
SCHEMBL9459002 0.72 CHRM2 (0.40) CHRM1CHRM2
SCHEMBL9458858 0.72 CHRM2 (0.47) CHRM2
Hydrochloric Acid SCHEMBL9459080 0.71
SCHEMBL9458919 0.69 CHRM2 (0.40) CHRM2
SCHEMBL7921990 0.68 CHRM2 (0.54) CHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0327155-A2 Pyrazines, pyrimidines and pyridazines, useful in the treatment of senile dementia MERCK SHARP & DOHME LTD. (GB) 1989-08-09 EP claimed
US-5574053-A Method for treating anxiety ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5574029-A Method for treating anxiety ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5260293-A Simulate central muscarinic acetlycholine receptors MERCK SHARP & DOHME LIMITED (GB) 1993-11-09 US disclosed
EP-0327155-A2 Pyrazines, pyrimidines and pyridazines, useful in the treatment of senile dementia MERCK SHARP & DOHME LTD. (GB) 1989-08-09 EP disclosed